Wow. What a privilege to have such brilliant scientist with world leading commercial acumen on the forum to call out a $200B organization on their stupidity. I agree, a $200B MC doesn't get you much when it comes to getting you the best scientists, regulatory, manufacturing, marketing or executives resources. If they only knew HC has some 'special' individuals who can cover all those skills at a fraction of the cost.
And there I was thinking our highest intellect contributor was the Top 20 holder of a major competitor in stem cells planning to do a reverse takeover of one of these multinationals once they complete a phase 3 study at before the decade is out.
Disclosure issues, page-40
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
0.023(2.12%) |
Mkt cap ! $1.218B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.10 | $1.06 | $1.673M | 1.554M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 9769 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 107153 | 6 |
View Market Depth
| Last trade - 12.57pm 03/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |